Haoxi Health Secures $6.46M in Registered Direct Offering at 5.5x Current Market Price, Addressing Going Concern

summarizeSummary

Haoxi Health Technology secured $6.46 million in a registered direct offering, priced at a substantial premium to its current market price, providing crucial capital for the financially distressed company despite significant potential dilution.

check_boxKey Events

• $6.46 Million Capital Raise

  The company will receive approximately $6.46 million in gross proceeds from the sale of 9,000,000 Class A Ordinary Shares and 16,999,998 pre-funded warrants.

• Significant Premium Pricing

  The offering price of $0.25 per share is a substantial premium compared to the last reported market price of $0.045 per share on May 11, 2026, indicating strong investor conviction.

• Substantial Potential Dilution

  The offering could result in approximately 315% potential dilution to existing shareholders if all pre-funded warrants to purchase up to 176,034,979 Class A Ordinary Shares are fully exercised.

• Addresses Going Concern Warning

  This capital infusion provides critical liquidity for the company, which recently disclosed a 'going concern' warning from its auditor and reported significant financial losses.

auto_awesomeAnalysis

Haoxi Health Technology has finalized a registered direct offering to raise approximately $6.46 million in gross proceeds by selling Class A Ordinary Shares and pre-funded warrants. This capital raise is critical for the company, which recently reported massive net losses and received a 'going concern' warning from its auditor. The offering is priced at $0.25 per share, a significant premium compared to the current market price of $0.045 per share, indicating strong investor confidence despite the company trading near its 52-week low. However, the offering involves substantial potential dilution of approximately 315% if all warrants are fully exercised, which will significantly increase the outstanding share count.